Become a fan of Slashdot on Facebook


Forgot your password?
Slashdot Deals: Cyber Monday Sale Extended! Courses ranging from coding to project management - all eLearning deals 20% off with coupon code "CYBERMONDAY20". ×

Submission + - Majority of landmark cancer studies cannot be replicated ( 3

Beeftopia writes: "NEW YORK (Reuters) — A former researcher at Amgen Inc has found that many basic studies on cancer — a high proportion of them from university labs — are unreliable, with grim consequences for producing new medicines in the future.

During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 "landmark" publications — papers in top journals, from reputable labs — for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development. Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature.

[...] But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers."

This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Majority of landmark cancer studies cannot be replicated

Comments Filter:

The first version always gets thrown away.